| NCI COVID-19 in Cancer Patients, NCCAPS Study |
Biospecimen Collection, Data Collection, Quality-of-Life Assessment, Questionnaire Administration |
Active, not recruiting |
| Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer |
Dexamethasone, Laboratory Biomarker Analysis, Netupitant/Palonosetron Hydrochloride, Olanzapine, Placebo, Prochlorperazine, Quality-of-Life Assessment |
Recruiting |
| Neuropsychological and Behavioral Testing in Younger Patients With Cancer |
Cognitive Assessment, Quality-of-Life Assessment |
Recruiting |
| New Assessment System in Measuring Symptom Distress in Cancer Patients |
Interview, Quality-of-Life Assessment, Questionnaire Administration |
Recruiting |
| Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer |
Questionnaire Administration, Paclitaxel, Placebo, Nilotinib, Nilotinib Hydrochloride Monohydrate |
Recruiting |
| Novel Strategy for Early Detection of Esophageal Squamous Cell Carcinoma |
Chromoendoscopy, EsoCAN assay, EsophaCap Sponge |
Recruiting |
| Novel, One Stop, Affordable, Point of Care and AI Supported System of Screening, Triage and Treatment Selection for Cervical Cancer in LMICs |
|
Recruiting |
| Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery |
Laboratory Biomarker Analysis, Nutritional Intervention, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration |
Active, not recruiting |
| Obeticholic Acid for Prevention in Barrett's Esophagus |
Biospecimen Collection, Esophageal Biopsy, Esophagogastroduodenoscopy, Liver Ultrasonographic Elastography, Obeticholic Acid, Placebo Administration, Questionnaire Administration |
Recruiting |
| Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients |
Megestrol Acetate, Olanzapine, Questionnaire Administration |
Recruiting |
| Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention |
omega 3 fatty acids |
Active, not recruiting |
| Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries |
S5 DNA methylation classifier, Xpert HPV |
Recruiting |
| Oral Iloprost for the Prevention of Lung Cancer In Former Smokers |
Biospecimen Collection, Placebo Administration, Bronchial Brush Biopsy, Iloprost, Questionnaire Administration, Bronchoscopy |
Not yet recruiting |
| Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia or Lobular Carcinoma In Situ |
Placebo, Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 4 mg/each breast/day |
Recruiting |
| Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer |
Palbociclib, Letrozole, Fulvestrant, Questionnaire Administration, Quality-of-Life Assessment |
Active, not recruiting |
| Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts |
Non-Interventional Study |
Not yet recruiting |
| Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment |
Enhanced Usual Care, Pathways |
Recruiting |
| Patient-centered and Efficacious Advance Care Planning in Cancer: the PEACe Comparative Effectiveness Trial |
Facilitated advance care planning (in-person or telephonic), Web-based advance care planning |
Active, not recruiting |
| Patient-Specific Decision Aid System for Shared Decision Making About Breast Reconstruction |
Conventional Imaging, Educational Intervention, Enhanced Consultation, Questionnaire Administration, Standard of Care Consultation |
Active, not recruiting |
| Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer |
Antitumor B |
Active, not recruiting |